Long-term methylone safety study for post-traumatic stress
About this title
Read the official source — NCT06237426Researchers studied Methylone to find out how it affected post-traumatic stress symptoms in people with PTSD.
Understand this study
What did researchers investigate?
Researchers studied Methylone to find out how it affected post-traumatic stress symptoms in people with PTSD.
Who was this study for?
This study was for people with PTSD. Listed age limits: 18 years to 71 years. Other eligibility criteria applied.
- Listed locations
- Denver and 8 more locationsSee all locations and recruitment
- Follow-up
- Up to 52 weeks
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 44
- Sponsor
- Transcend Therapeutics
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States, United Kingdom, Ireland
- Age range
- From 18 Years to 71 Years
- Official registry ID
- NCT06237426
- Official title
Show the full official title
A 52-Week, Open-Label Evaluation of the Long-term Efficacy and Safety of Single and Repeated Treatments With Methylone for the Treatment of PTSD IMPACT-EXT (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Denver, United States · Rockville, United States · Draper, United States
5 more locations
- Galway, Ireland
- Cambridge, United Kingdom
- Belfast, United Kingdom
- Glasgow, United Kingdom
- London, United Kingdom
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers studied Methylone to find out how it affected post-traumatic stress symptoms in people with PTSD.
Who is behind this study?
The study sponsor is Transcend Therapeutics.
Did this study involve medication?
Yes. The study involved medication, including Methylone.
Who was this study for?
This study was for people with PTSD. Listed age limits: 18 years to 71 years. Other eligibility criteria applied.
